Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients.
An G, Creech CB, Wu N, Nation RL, Gu K, Nalbant D, Jimenez-Truque N, Fissell W, Patel PC, Fishbane N, Watanabe A, Rolsma S, Kirkpatrick CMJ, Landersdorfer CB, Winokur P. An G, et al. Among authors: nation rl. J Antimicrob Chemother. 2023 Jun 1;78(6):1460-1470. doi: 10.1093/jac/dkad106. J Antimicrob Chemother. 2023. PMID: 37071586 Free PMC article.
Colistin: how should it be dosed for the critically ill?
Landersdorfer CB, Nation RL. Landersdorfer CB, et al. Among authors: nation rl. Semin Respir Crit Care Med. 2015 Feb;36(1):126-35. doi: 10.1055/s-0034-1398390. Epub 2015 Feb 2. Semin Respir Crit Care Med. 2015. PMID: 25643276 Review.
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
Jitmuang A, Nation RL, Koomanachai P, Chen G, Lee HJ, Wasuwattakul S, Sritippayawan S, Li J, Thamlikitkul V, Landersdorfer CB. Jitmuang A, et al. Among authors: nation rl. J Antimicrob Chemother. 2015;70(6):1804-11. doi: 10.1093/jac/dkv031. Epub 2015 Feb 18. J Antimicrob Chemother. 2015. PMID: 25698772
Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
Yadav R, Bulitta JB, Nation RL, Landersdorfer CB. Yadav R, et al. Among authors: nation rl. Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01011-16. doi: 10.1128/AAC.01011-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27821448 Free PMC article.
Substantial Impact of Altered Pharmacokinetics in Critically Ill Patients on the Antibacterial Effects of Meropenem Evaluated via the Dynamic Hollow-Fiber Infection Model.
Bergen PJ, Bulitta JB, Kirkpatrick CMJ, Rogers KE, McGregor MJ, Wallis SC, Paterson DL, Nation RL, Lipman J, Roberts JA, Landersdorfer CB. Bergen PJ, et al. Among authors: nation rl. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02642-16. doi: 10.1128/AAC.02642-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28264846 Free PMC article.
Evaluation of Pharmacokinetic/Pharmacodynamic Model-Based Optimized Combination Regimens against Multidrug-Resistant Pseudomonas aeruginosa in a Murine Thigh Infection Model by Using Humanized Dosing Schemes.
Yadav R, Bulitta JB, Wang J, Nation RL, Landersdorfer CB. Yadav R, et al. Among authors: nation rl. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01268-17. doi: 10.1128/AAC.01268-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28993331 Free PMC article.
354 results